China Minsheng Investment Group has led a RMB200 million ($29 million) series B round in karaoke provider Thunder Stone Technology while China Medical Venture Investment (CMVI) has invested $12.7 million in UK-based drug company Blueberry Therapeutics.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
